Literature DB >> 15246628

Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application.

Antonella Caputo1, Egidio Brocca-Cofano, Arianna Castaldello, Rita De Michele, Giuseppe Altavilla, Marco Marchisio, Riccardo Gavioli, Ulrika Rolen, Laura Chiarantini, Aurora Cerasi, Sabrina Dominici, Mauro Magnani, Aurelio Cafaro, Katia Sparnacci, Michele Laus, Luisa Tondelli, Barbara Ensoli.   

Abstract

Two novel classes of biocompatible core-shell anionic microspheres, composed of an inner hard insoluble core, either made of poly(styrene) (PS) or poly(methyl methacrylate) (PMMA), and a soft outer tentacular shell made of long soluble negatively charged arms derived from the steric stabilizer, hemisuccinated poly(vinyl alcohol) or Eudragit L100/55, respectively, were prepared by dispersion polymerization and characterized. Five types of these novel microspheres, two made of poly(styrene) and hemisuccinated poly(vinyl alcohol) (A4 and A7), and three made of poly(methyl methacrylate) and Eudragit L100/55 (1D, 1E, H1D), differing for chemical composition, size, and surface charge density were analyzed for the delivery of the HIV-1 Tat protein for vaccine applications. All microspheres reversibly adsorbed the native biologically active HIV-1 Tat protein preventing Tat from oxidation and maintaining its biological activity, therefore increasing the shelf-life of the Tat protein vaccine. The microspheres efficiently delivered Tat intracellularly, and were not toxic in vitro nor in mice, even after multiple administrations. These results indicate that these novel microparticles are safe and represent a promising delivery system for vaccination with Tat, as well as for other subunit vaccines, particularly when a native protein conformation is required.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246628     DOI: 10.1016/j.vaccine.2003.12.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.

Authors:  Valentina Finessi; Francesco Nicoli; Eleonora Gallerani; Fabio Sforza; Mariaconcetta Sicurella; Aurelio Cafaro; Antonella Caputo; Barbara Ensoli; Riccardo Gavioli
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes.

Authors:  Rebecca Voltan; Arianna Castaldello; Egidio Brocca-Cofano; Giuseppe Altavilla; Antonella Caputo; Michele Laus; Katia Sparnacci; Barbara Ensoli; Silvia Spaccasassi; Marco Ballestri; Luisa Tondelli
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

3.  Treatment with gentamicin on a murine model of protothecal mastitis.

Authors:  Ruilong Chang; Qiaoling Yang; Gang Liu; Yongxia Liu; Bowen Zheng; Jingliang Su; Bo Han
Journal:  Mycopathologia       Date:  2013-03-06       Impact factor: 2.574

4.  Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse.

Authors:  Paola Rimessi; Patrizia Sabatelli; Marina Fabris; Paola Braghetta; Elena Bassi; Pietro Spitali; Gaetano Vattemi; Giuliano Tomelleri; Lara Mari; Daniela Perrone; Alessandro Medici; Marcella Neri; Matteo Bovolenta; Elena Martoni; Nadir M Maraldi; Francesca Gualandi; Luciano Merlini; Marco Ballestri; Luisa Tondelli; Katia Sparnacci; Paolo Bonaldo; Antonella Caputo; Michele Laus; Alessandra Ferlini
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

Review 5.  Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy.

Authors:  Maria Sofia Falzarano; Chiara Passarelli; Alessandra Ferlini
Journal:  Nucleic Acid Ther       Date:  2014-02       Impact factor: 5.486

6.  Protective effect of recombinant staphylococcal enterotoxin A entrapped in polylactic-co-glycolic acid microspheres against Staphylococcus aureus infection.

Authors:  Liben Chen; Shuang Li; Zhengfang Wang; Ruilong Chang; Jingliang Su; Bo Han
Journal:  Vet Res       Date:  2012-03-19       Impact factor: 3.683

7.  Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines.

Authors:  Fausto Titti; Maria T Maggiorella; Flavia Ferrantelli; Leonardo Sernicola; Stefania Bellino; Barbara Collacchi; Emanuele Fanales Belasio; Sonia Moretti; Maria Rosaria Pavone Cossut; Roberto Belli; Erika Olivieri; Stefania Farcomeni; Daniela Compagnoni; Zuleika Michelini; Michela Sabbatucci; Katia Sparnacci; Luisa Tondelli; Michele Laus; Aurelio Cafaro; Antonella Caputo; Barbara Ensoli
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

8.  Predicting Drug Release Rate of Implantable Matrices and Better Understanding of the Underlying Mechanisms through Experimental Design and Artificial Neural Network-Based Modelling.

Authors:  Ernő Benkő; Ilija German Ilič; Katalin Kristó; Géza Regdon; Ildikó Csóka; Klára Pintye-Hódi; Stane Srčič; Tamás Sovány
Journal:  Pharmaceutics       Date:  2022-01-19       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.